Literature DB >> 10864634

Deletion mutagenesis downstream of the 5' long terminal repeat of human immunodeficiency virus type 1 is compensated for by point mutations in both the U5 region and gag gene.

C Liang1, L Rong, R S Russell, M A Wainberg.   

Abstract

We have studied the role of an RNA region at nucleotides (nt) +200 to +233, just downstream of the 5' long terminal repeat, in encapsidation of human immunodeficiency virus type 1 genomic RNA. Three deletion mutations, namely, BH-D0, BH-D1, and BH-D2, were generated to eliminate sequences at positions nt +200 to +219, +200 to +226, and +200 to +233. The result in each case was decreased levels of packaging of viral RNA into the mutated viruses, with the BH-D2 virus being the most severely affected. Consistently, all three deletions resulted in impaired viral infectiousness and the BH-D2 mutation showed the most dramatic impact in this regard. Further analysis revealed additional defects in Gag precursor processing and in the extension efficiency of the tRNA(3)(Lys) primer in reverse transcription reactions performed with these mutated viruses. To shed further light on the function of these deleted sequences in viral replication, the mutated viruses were cultured in MT-2 cells over prolonged periods to enable them to reacquire wild-type replication kinetics. Sequencing of the reverted viruses revealed point mutations in both the noncoding region and the gag gene. In the case of the BH-D0 revertant, two mutations were observed at positions G112A in the U5 region, termed M1, and T24I in the nucleocapsid protein, termed MNC, respectively. Either of these two mutations was able to confer wild-type replication capacity on BH-D0. In the case of BH-D1, each of the M1 mutations, a mutation termed M2, i.e., C227T, just downstream of the primer binding site, a mutation termed MP2 (T12I) in the p2 protein, and the MNC mutation were observed. A combination of either M1 and M2 or MP2 and MNC was able to rescue BH-D1. In the case of the BH-D2 deletion-containing viruses, three point mutations, i.e., M1, MP2, and MNC, were observed and the presence of all three was required to restore viral replication to wild-type levels.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10864634      PMCID: PMC112130          DOI: 10.1128/jvi.74.14.6251-6261.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus.

Authors:  A Aldovini; R A Young
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

2.  The human immunodeficiency virus type 1 packaging signal and major splice donor region have a conserved stable secondary structure.

Authors:  G P Harrison; A M Lever
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

3.  Characterization of human immunodeficiency virus type 1 dimeric RNA from wild-type and protease-defective virions.

Authors:  W Fu; R J Gorelick; A Rein
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

4.  Identification of the primary site of the human immunodeficiency virus type 1 RNA dimerization in vitro.

Authors:  E Skripkin; J C Paillart; R Marquet; B Ehresmann; C Ehresmann
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

5.  Dimerization of human immunodeficiency virus type 1 RNA involves sequences located upstream of the splice donor site.

Authors:  R Marquet; J C Paillart; E Skripkin; C Ehresmann; B Ehresmann
Journal:  Nucleic Acids Res       Date:  1994-01-25       Impact factor: 16.971

6.  A 19-nucleotide sequence upstream of the 5' major splice donor is part of the dimerization domain of human immunodeficiency virus 1 genomic RNA.

Authors:  M Laughrea; L Jetté
Journal:  Biochemistry       Date:  1994-11-15       Impact factor: 3.162

7.  Functional sites in the 5' region of human immunodeficiency virus type 1 RNA form defined structural domains.

Authors:  F Baudin; R Marquet; C Isel; J L Darlix; B Ehresmann; C Ehresmann
Journal:  J Mol Biol       Date:  1993-01-20       Impact factor: 5.469

8.  The two zinc fingers in the human immunodeficiency virus type 1 nucleocapsid protein are not functionally equivalent.

Authors:  R J Gorelick; D J Chabot; A Rein; L E Henderson; L O Arthur
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

9.  Packaging of human immunodeficiency virus type 1 RNA requires cis-acting sequences outside the 5' leader region.

Authors:  J H Richardson; L A Child; A M Lever
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

10.  Specific binding of HIV-1 nucleocapsid protein to PSI RNA in vitro requires N-terminal zinc finger and flanking basic amino acid residues.

Authors:  J Dannull; A Surovoy; G Jung; K Moelling
Journal:  EMBO J       Date:  1994-04-01       Impact factor: 11.598

View more
  10 in total

1.  HIV-1 Employs Multiple Mechanisms To Resist Cas9/Single Guide RNA Targeting the Viral Primer Binding Site.

Authors:  Zhen Wang; Wenzhou Wang; Ya Cheng Cui; Qinghua Pan; Weijun Zhu; Patrick Gendron; Fei Guo; Shan Cen; Michael Witcher; Chen Liang
Journal:  J Virol       Date:  2018-09-26       Impact factor: 5.103

2.  An intact U5-leader stem is important for efficient replication of simian immunodeficiency virus.

Authors:  Y Guan; K Diallo; J B Whitney; C Liang; M A Wainberg
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

3.  Hydrophobic amino acids in the human immunodeficiency virus type 1 p2 and nucleocapsid proteins can contribute to the rescue of deleted viral RNA packaging signals.

Authors:  L Rong; R S Russell; J Hu; Y Guan; L Kleiman; C Liang; M A Wainberg
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

4.  Novel, live attenuated simian immunodeficiency virus constructs containing major deletions in leader RNA sequences.

Authors:  Y Guan; J B Whitney; C Liang; M A Wainberg
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

5.  Specific inhibition of the synthesis of human lysyl-tRNA synthetase results in decreases in tRNA(Lys) incorporation, tRNA(3)(Lys) annealing to viral RNA, and viral infectivity in human immunodeficiency virus type 1.

Authors:  Fei Guo; Shan Cen; Meijuan Niu; Hassan Javanbakht; Lawrence Kleiman
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

6.  The simian immunodeficiency virus 5' untranslated leader sequence plays a role in intracellular viral protein accumulation and in RNA packaging.

Authors:  Jignesh Patel; Shainn-Wei Wang; Elena Izmailova; Anna Aldovini
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

Review 7.  Clinical significance of human immunodeficiency virus type 1 replication fitness.

Authors:  Carrie Dykes; Lisa M Demeter
Journal:  Clin Microbiol Rev       Date:  2007-10       Impact factor: 26.132

8.  Effects of a single amino acid substitution within the p2 region of human immunodeficiency virus type 1 on packaging of spliced viral RNA.

Authors:  Rodney S Russell; Ariel Roldan; Mervi Detorio; Jing Hu; Mark A Wainberg; Chen Liang
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

Review 9.  Is HIV-1 RNA dimerization a prerequisite for packaging? Yes, no, probably?

Authors:  Rodney S Russell; Chen Liang; Mark A Wainberg
Journal:  Retrovirology       Date:  2004-09-02       Impact factor: 4.602

Review 10.  Coordination of Genomic RNA Packaging with Viral Assembly in HIV-1.

Authors:  Chris Hellmund; Andrew M L Lever
Journal:  Viruses       Date:  2016-07-14       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.